|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910457507503321 |
|
|
Titolo |
A handbook of vascular disease management [[electronic resource] /] / Wesley S. Moore, Juan Carlos Jimenez, editors |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Singapore, : World Scientific, c 2011 |
|
|
|
|
|
|
|
ISBN |
|
1-283-43345-1 |
9786613433459 |
981-4317-78-0 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (343 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
MooreWesley S |
JiménezJuan Carlos |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Blood-vessels - Diseases |
Blood-vessels - Diseases - Treatment |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Contents; Contributors; 1. Atherosclerosis: Basic Principles and Medical Management; 1. Introduction; 2. Pathogenesis of Atherosclerosis; 2.1 Normal arterial anatomy; 2.2 Etiology and progression of disease; 2.2.1 Intimal thickening; 2.2.2 Fatty streaks; 2.2.3 Fibrofatty lesions/gelatinous plaques; 2.2.4 Fibrous plaques; 2.2.5 Complicated lesions; 2.3 Classification of vascular lesions; 2.4 Atherosclerosis at the cellular level; 2.4.1 Endothelium; 2.4.2 Smooth muscle cells; 2.4.3 Macrophages; 3. Theories of Atherogenesis; 3.1 Response to injury hypothesis; 3.2 Lipid hypothesis |
3.3 Thrombogenic hypothesis3.4 Mesenchymal hypothesis; 3.5 Monoclonal hypothesis; 4. Lesion Arrest and Regression -Plaque Modification; 5. Mechanism of Injury; 5.1 Tobacco; 5.2 Hypertension; 5.3 Shear forces; 5.4 Hyperlipidemia; 5.5 Diabetes; 5.6 Infection; 6. Atherosclerosis Basic Principles and Medical Management; 6.1 Risk factors for atherosclerotic disease and modification strategies; 6.2 Smoking; 6.3 Diabetes mellitus; 6.4 Hypertension; 6.5 Dyslipidemia; 6.6 Metabolic syndrome; 6.7 Emerging novel risk factors; 6.8 Surveillance and secondary prevention; 7. Conclusions; References |
|
|
|
|